Drug Topics
MAY 29, 2024
While US health officials continue to monitor the outbreak in dairy cattle across the country, a second human recently tested positive after a mutation of the bird flu virus.
PharmaVoice
MAY 29, 2024
A partnership between the cell therapy delivery specialist Portal Biotechnologies and precision robotics maker Multiply Labs could bring the manufacturing bottleneck under control, the CEOs said.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
MAY 29, 2024
Check out this list of our 10 most read stories from May 2024.
PharmaVoice
MAY 29, 2024
As Novo Nordisk aims to secure its manufacturing foothold for GLP-1s, regulators are digging for clues of anti-competitive behavior.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
MAY 29, 2024
Patients with type 2 diabetes who used continuous glucose monitors combined with regular exercise had improved fasting glucose and 2 hours-postprandial glucose levels.
STAT
MAY 29, 2024
Menstruation is a critical indicator of health. Whether and when someone with a uterus gets their period — for the first time, and throughout their life — can reflect not only their reproductive health, but their risk of cardiovascular disease, cancer, miscarriage, and premature death. That also makes menstruation a useful measure of population health.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
MAY 29, 2024
Health insurers are telling shareholders that they are ramping up the use of artificial intelligence and are hiring talent to implement the technology across their organizations. They say their artificial intelligence models can increase efficiency and “cut costs,” but they refused to discuss what models they’re using, how those models were developed, or exactly what they’re using them for.
Pharmacy Times
MAY 29, 2024
The treatment is the first liquid non-stimulant for attention deficit hyperactivity disorder to be approved in the United States.
STAT
MAY 29, 2024
STAT teamed up with Word In Black, a network of 10 Black news publishers, to report over the past year on the impact of new weight loss drugs on Black America. Jonathan Gustave was diagnosed with type 2 diabetes last August after decades of struggling with his weight. To help lower his blood sugar levels, his doctor prescribed Ozempic, the diabetes drug that has become wildly popular for its weight loss effects.
Pharmacy Times
MAY 29, 2024
Eculizumab-aeeb (Bkemv; Amgen) is approved for the treatment of paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
MAY 29, 2024
STAT teamed up with Word In Black, a network of 10 Black news publishers, to report over the past year on the impact of new weight loss drugs on Black America. When was the last time you thought about your weight?
Pharmacy Times
MAY 29, 2024
Gender disparities among oncology health care professionals have significant consequences for both the physicians and the patients they treat.
STAT
MAY 29, 2024
WASHINGTON — Clinical trials that the National Institutes of Health funds often enroll fewer Black patients and other underrepresented racial groups than they plan to, according to a study of 30 NIH-funded trials sampled by the HHS Office of Inspector General. Policymakers want to get researchers to enroll a racially representative sample of patients in clinical trials that test whether products work and are safe.
Pharmacy Times
MAY 29, 2024
Although questions remain about ideal treatment strategies, consistent data have shown that patients should be treated early.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
MAY 29, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. I hope everyone had a restful Memorial Day weekend. I myself was engaged in what my editor calls one of the greatest joys in life — packing up all my belongings, moving two miles, and then unpacking all of my belongings.
Pharmacy Times
MAY 29, 2024
Penelope Murphy discusses the role that preceptors play in mentoring students and new pharmacists to help bridge the gap between classroom learning and real-world practice.
STAT
MAY 29, 2024
A month after announcing it was seeking strategic alternatives , Akili Interactive, maker of a video game designed to treat ADHD, said it will go private in a merger with Virtual Therapeutics. The deal is expected to net Akili’s shareholders $34 million. Akili made headlines in 2020 when it received Food and Drug Administration clearance for EndeavorRx, a video game designed to treat pediatric ADHD.
Fierce Healthcare
MAY 29, 2024
Imagine360, a self-funded health plan out of Pennsylvania, reduces healthcare costs significantly more than major national carriers, an actuarial analysis by Axene Health Partners found. | Imagine360, an alternative health plan in Pennsylvania, is pointing to an independent analysis showing its clients save 20% on health benefit costs when compared to traditional carriers.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
MAY 29, 2024
A group representing clinical labs across the country sued the Food and Drug Administration on Wednesday over the agency’s plan to actively regulate lab-developed tests. The suit, filed in a Texas federal court by the American Clinical Laboratory Association and PCR lab HealthTrackRx, claims the FDA does not have the authority to scrutinize lab-developed tests.
Pharmacy Times
MAY 29, 2024
A methodical approach can optimize the evaluation of a paper.
STAT
MAY 29, 2024
Researchers may have a new way to watch the brain pulse, thanks to an ultrasound probe and a tiny window in the skull. This acoustically transparent hole allowed a team in California to capture, using functional ultrasound imaging, an extraordinary view of human brain activity of very normal hobbies, according to a study published Wednesday in Science Translational Medicine.
Fierce Healthcare
MAY 29, 2024
This week on "Podnosis," we dive into the topic of telehealth and its role in a comprehensive approach to healthcare. | This week on "Podnosis," Emma Beavins from Fierce Healthcare interviews CVS Health Chief Medical Officer Sree Chaguturu, M.D., to dive into the topic of telehealth and its role in a comprehensive approach to healthcare.
STAT
MAY 29, 2024
Biohaven Pharmaceuticals said Wednesday that a new type of experimental medicine reduced levels of a disease-causing immune molecule by up to 37% in an early-stage study of human volunteers — a result that the company called “positive” as a proof of concept but that also fell short of investor expectations. The drug, called BHV-1300, belongs to a new class of antibody medicines that shuttle harmful proteins to the liver so they can be removed from the body.
pharmaphorum
MAY 29, 2024
More consolidation in the digital health sector as Akili agrees a $34m takeover by Virtual Therapeutics, returning to private hands.
STAT
MAY 29, 2024
If there were ever to be an empty bed in the stress unit my psychiatrist dad manages, I’m certain he would admit himself. He runs the only private psychiatric practice in the rural Michigan town of Owosso and is the sole psychiatrist contracted at the local hospital. With approximately 1 in every 10 of the town’s 15,000 residents being a patient in his practice, he shoulders the responsibility for many more patients than most psychiatrists do.
pharmaphorum
MAY 29, 2024
In a new episode of the pharmaphorum podcast, Rahul Kakkar, CEO of gene editing company Tome, speaks with web editor Nicole Raleigh about programmable genomic integration (PGI) technology.
STAT
MAY 29, 2024
If an effective treatment is available for one common disease in men, and that same treatment is available for a different common disease in women, a logical expectation would be that the treatments are equally accessible to men and women. That is not the current reality. The treatment I am talking about is focused ultrasound. It has been approved by the Food and Drug Administration for a range of conditions, including prostate cancer, fibroids, liver tumors, essential tremor and Parkinsonȁ
Fierce Healthcare
MAY 29, 2024
Direct-to-consumer health and wellness company Ro launched an online GLP-1 supply tracker as an interactive tool to give patients real-time insights on GLP-1 drug shortages. | Direct-to-consumer health and wellness company Ro launched an online GLP-1 supply tracker as an interactive tool to give patients real-time insights on GLP-1 drug shortages.
STAT
MAY 29, 2024
LONDON — Merck is buying ophthalmology-focused startup EyeBio in a deal worth up to $3 billion, according to media reports, as the pharma company looks to diversify its pipeline. Under the deal, Merck will pay $1.3 billion upfront, with another $1.7 billion if certain milestones are met. The Wall Street Journal first reported the news Tuesday night, and EyeBio’s CEO and board chair outlined in the deal in an interview with the Financial Times published Wednesday.
Fierce Healthcare
MAY 29, 2024
A new review of California patient volumes is the latest warning that hospital ransomware attacks have consequences that extend to other providers in their surrounding community. | While inpatient admissions and ED visits decline for weeks at a targeted hospital, those in the surrounding areas can expect up to 7% more ED visits, according to a recently published analysis of ransomware attacks among California hospitals.
STAT
MAY 29, 2024
When it comes to childhood and young adulthood, most people in the U.S. think of carefree times of life with few major responsibilities. But for a small subset of young people, these years also mean caring for loved ones. Harvard medical students Kimia Heydari and Romila Santra both have firsthand experience being young caregivers, and they wrote about this often overlooked group in their First Opinion essay “ Caring for young caregivers, a hidden population.
pharmaphorum
MAY 29, 2024
MSD has confirmed a $3 billion takeover deal for ophthalmology biotech EyeBio and its drug candidate for diabetic macular oedema (DME) and neovascular age-related macular degeneration (AMD).
The Guardian - Pharmaceutical Industry
MAY 29, 2024
Letter urges US company Gilead Sciences to ‘shape history’ by providing fair access Former world leaders, celebrities and a Nobel prize-winning scientist who helped discover HIV have written to a leading pharmaceutical company to urge it to make a “gamechanger” HIV medicine available to people living outside wealthy countries. The US company Gilead Sciences has been urged to “shape history” by avoiding a repeat of the “horror and shame” of the early years of the Aids pandemic, when 12 million li
Expert insights. Personalized for you.
496 
Let's personalize your content